In a mouse model of melanoma, in vivo treatment of RAG-/- mice (which lack functional T cells) with PD-L1 antibodies triggers TAM activation to a proinflammatory state and a significant slowing of tumor growth which is independent of T cells, the main target for immune checkpoint blockers (118). Here, CD274 is linked to neoplasm.